<DOC>
	<DOCNO>NCT02909517</DOCNO>
	<brief_summary>This prospective , non-therapeutic study determine whether novel image technique identify presumptive tumour associate macrophage ( TAMs ) patient ocular tumour . In study , modify standard angiography protocol patient return twice week follow angiography additional photograph . Photographs obtain 2-7 day angiography , without injection dye . This technique contrast normal angiography photograph take transit phase dye circulation minute thereafter . Of note , dye camera use detection approve clinical use several decade routinely used evaluation patient ocular tumour . We evaluate 5 group : 1 . Choroidal nevus ( low-risk feature ) : require distinction melanoma diagnostic test 2 . Choroidal indeterminate melanocytic lesion ( high-risk feature ) : require diagnostic test identification distinction nevus melanoma 3 . Choroidal melanoma : require confirmation diagnosis evaluation potential metatstases 4 . Suspected metastatic tumour ( ie , primary tumour elsewhere ) : require identification primary tumour 5 . Locally treat ocular tumour : require followup evaluate response treatment potential change repeat therapy</brief_summary>
	<brief_title>The Role Inflammation Ocular Tumours</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Eye Neoplasms</mesh_term>
	<criteria>Any tentative clinical diagnosis : 1 . Choroidal nevus ( lowrisk feature ) : 2 . Choroidal indeterminate melanocytic lesion ( highrisk feature ) 3 . Choroidal melanoma 4 . Suspected metastatic tumour ( ie , primary tumour elsewhere ) 5 . Locally treat ocular tumour Note patient enroll study twice , treatment , provide least one month pass since initiation treatment . This patient count twice ( ie , two study arm ) Male female age 18 year old Ability provide inform consent Allergy angiography dye Cases meet criterion tumor size ineligible participate study . Patients able provide consent study . Patients poor view fundus due cataract vitreous hemorrhage . Patients &lt; 18 year age . Any concurrent unrelated eye diagnosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>